New drug enables infants with genetic disorder to live longer, gain motor function

(Nemours) Infants with the most severe form of spinal muscular atrophy (SMA) were more likely to show gains in motor function and were 47 percent more likely to survive without permanent assisted ventilation support when treated with a new medication, according to a study published today in the New England Journal of Medicine.
Source: EurekAlert! - Biology - Category: Biology Source Type: news